How many insider declarations has Hillhouse Investment Management, Ltd. filed?

Hillhouse Investment Management, Ltd. has filed 3 public insider declarations with SEC (Form 4).

What is Hillhouse Investment Management, Ltd.'s role?

Hillhouse Investment Management, Ltd.'s reported role is not specified by the regulator across the filings.

Which companies does Hillhouse Investment Management, Ltd. report trades for?

Hillhouse Investment Management, Ltd. reports trades for 2 companies, including Enfusion, Inc..

What is Hillhouse Investment Management, Ltd.'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 20.0M€.

← Executives ★ Sign in to follow

HI

Hillhouse Investment Management, Ltd.

Other

·SEC (Form 4)

Enfusion, Inc.ArriVent Biopharma, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€2003万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the full record of transactions filed by Hillhouse Investment Management, Ltd.. Officer active across 2 companies, notably Enfusion, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €20m. Activity tracked since 25 October 2021. The latest transaction was disclosed on 10 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Hillhouse Investment Management, Ltd.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Enfusion, Inc. (US)ArriVent Biopharma, Inc. (US)

申报3 总计

▼

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

高管2025年12月10日ArriVent Biopharma, Inc.

US$1298万10SEC ↗

555,555 股@ US$23.37100.0% 占其流量Common StockSEC:0000902664-26-000675:0

●

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

高管2024年1月30日ArriVent Biopharma, Inc.

0SEC ↗

3,616,041 股Common StockSEC:0000902664-24-000903:0

▼

HILLHOUSE INVESTMENT MANAGEMENT, LTD.

高管2021年10月25日Enfusion, Inc.

US$1030万22SEC ↗

647,862 股@ US$15.895100.0% 占其流量Class A common stock, par value $0.001 per shareSEC:0000902664-21-004622:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

HI

Hillhouse Investment Management, Ltd.

Other

·SEC (Form 4)

Enfusion, Inc.ArriVent Biopharma, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€2003万

▼ 卖出（2 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

2

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the full record of transactions filed by Hillhouse Investment Management, Ltd.. Officer active across 2 companies, notably Enfusion, Inc.. Aggregated, 3 filings have been logged. Split: 0 buy · 2 sells. Total volume traded: €20m. Activity tracked since 25 October 2021. The latest transaction was disclosed on 10 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.